Pilot scale production of a biologically active polysaccharide from a marine microalga using photobioreactor technology

总部位于苏格兰的生物技术公司GlycoMar Limited和总部位于挪威的微藻和光生物反应器(PBR)技术公司MicroA AS正在提出一个可行性项目，以评估从海洋微藻中生产已确定的高价值化妆品成分的中试规模。该项目将使用MicroA最近获得专利的PBR技术作为GlycoMar微藻多糖产品开发的放大平台。MicroA将使用他们的中试规模系统(200升)来优化生长条件，以最大限度地生产藻类多糖。GlycoMar将优化下游加工，以最大限度地回收目标产品。该项目将确立全面生产的商业可行性。该项目的成功将是合作伙伴公司以及更广泛的生物技术和微藻行业的一个重要里程碑，并将在3年内作为一种高价值的天然护肤成分实现商业化。

GlycoMar Limited, a biotechnology company based in Scotland, and MicroA AS, a microalgae and photobioreactor (PBR) technology company based in Norway, are proposing a feasibility project to evaluate the pilot scale production of an identified high value cosmetic ingredient from a marine microalga. The project will use MicroA’s recently patented PBR technology as the scale-up platform for GlycoMar’s microalgal polysaccharide product development. MicroA will use their pilot scale system (200 litres) to optimise growth conditions for maximum algal polysaccharide production. GlycoMar will optimise downstream processing to maximise recovery of the target product. The project will establish the commercial viability of full-scale production. Success of the project will be an important milestone for both partner companies and the wider biotechnology and microalgae industries, and will lead to commercialisation as a high value natural skin care ingredient within 3 years.